Dossier
University of
Coverage of University of in the Nexus archive.
- America’s Split Economy: The Boom and the Worker
AbbVie agreed to acquire Apogee Therapeutics for $10.9 billion in a debt-funded deal, offering a 49% premium over Apogee’s June 18 closing share price. The transaction reflects a long-term investment in the company’s future growth.